Spyre Therapeutics Inc (SYRE) Price Prediction & ForecastSYRESpyre Therapeutics Inc

Alphio's SYRE stock price prediction model matches the current Spyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $91.13 (+0.85%). The 1-week path is $94.14 (+4.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Spyre Therapeutics Inc is currently not a good buy. The stock is trading at $90.36, with a 5-day change of -15.15% and an RSI of 16.467, indicating it is oversold. Despite a strong year-to-date change of +195.49% and a one-year change of +443.36%, the recent insider selling and downgrades in analyst price targets suggest caution. The main risk is the significant net losses, with a reported net income of -$69 million for Q1 2026, which raises concerns about sustainability.

Spyre Therapeutics Inc (SYRE) last closed at $90.36, losing -3.48%. These facts feed the 1-day and 1-week SYRE price prediction above.